ClinicalTrials.gg
CompletedNCT01155687Updated Aug 9, 2011

Psychosocial Counseling in Afghanistan

An observational study in Mental Health and Stress, sponsored by University of Konstanz. Completed at 1 site in Afghanistan. Open to participants aged 14 Years and older. Per ClinicalTrials.gov, last updated 2011-08-09.

Sponsored by University of Konstanz · Observational

Study type
Observational
Model
Case-control
Enrollment
61
Ages
14 Years and older
Sex
All
01

Study summary

The assessment intends to investigate the efficacy of psychosocial counseling for the treatment of help seeking individuals with psychosocial problems in Mazar-e-Sharif, Afghanistan. Treatment was administered by local counselors who had received specific education and training

Read the detailed description

Psychosocial stress due to conflict and war causes major mental health problems in many resource-poor countries, especially those coping with ongoing war-like conditions. There is a lack of intervention research in these population. The purpose of this assessment was to examine whether the type of psychosocial counseling developed by our group is effective in reducing symptoms of depression and anxiety and significantly increasing the quality of life of help-seeking Afghans.

02

Conditions studied

  • Mental Health
  • Stress

Keywords

  • afghanistan
  • depression
  • anxiety
  • social stress
  • counseling
  • medication
  • psychotherapy
  • mental health
03

In context

Psychological Well-Being

1,045 studies on the registry are indexed under Psychological Well-Being; 509 are open to participants now.

This study's enrollment of 61 is below the median of 200 across 146 observational studies indexed under Psychological Well-Being.

Browse Psychological Well-Being studies →

Lead sponsor

University of Konstanz is the lead sponsor of 51 studies on the registry; none are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
14 Years and older
Sexes eligible
All
Accepts healthy volunteers
No
Sampling method
Probability sample

Study population

Afghan people at primary care clinic seeking help because of mental health problems

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Diagnosis of mental health problems by a local medical doctor

Exclusion criteria

Exclusion Criteria:

  • Schizophrenia
  • Mental retardation
05

Study design

Observational model
Case-control
Enrollment
61 participants (actual)

Groups and cohorts

  • Psychosocial counseling

    the group received annualized treatment of psychosocial counseling

  • Medication

    this group received medical treatment by the local medical doctor

06

What researchers measure

Primary outcomes

  1. HSCL 25

    Symptoms of Depression and Anxiety measured with the HSCL 25

    Time frame: Symptoms were assessed at baseline

  2. HSCL 25

    Symptoms of Depression and Anxiety measured with the HSCL 25

    Time frame: 3-month follow-up

  3. HSCL 25

    Symptoms of Depression and Anxiety measured with the HSCL 25

    Time frame: Assessment at 12-month-follow-up

Secondary outcomes

  1. M.I.N.I. (Mini-International Neuropsychiatric Interview)

    To assess, if the patients have a current Major Depression, the depression section from the "Mini-International Neuropsychiatric Interview" (Sheehan, \& Janavs, 1998) was included

    Time frame: Symptoms were assessed at baseline

  2. Psychosocial stressors and coping mechanism

    Psychosocial stressors and coping mechanism of the participants were investigated in expert interviews

    Time frame: Symptoms were assessed at baseline

  3. Screening for Depression

    A culturally grounded assessment measure developed in close collaboration with a team of Afghan experts explored current depressive symptoms

    Time frame: Symptoms were assessed at baseline

  4. M.I.N.I. (Mini-International Neuropsychiatric Interview)

    To assess, if the patients have a current Major Depression, the depression section from the "Mini-International Neuropsychiatric Interview" (Sheehan, \& Janavs, 1998) was included

    Time frame: Assessment at 3-month-follow-up

  5. M.I.N.I (Mini-International Neuropsychiatric Interview)

    To assess, if the patients have a current Major Depression, the depression section from the "Mini-International Neuropsychiatric Interview" (Sheehan, \& Janavs, 1998) was included

    Time frame: Assessment at 12-month-follow-up

  6. Psychosocial stressors and coping mechanism

    Psychosocial stressors and coping mechanism of the participants were investigated in expert interviews

    Time frame: Assessment at 3-month-follow-up

  7. Psychosocial stressors and coping mechanism

    Psychosocial stressors and coping mechanism of the participants were investigated in expert interviews

    Time frame: Assessment at 12-month-follow-up

  8. Screening for Depression

    A culturally grounded assessment measure developed in close collaboration with a team of Afghan experts explored current depressive symptoms

    Time frame: Assessment at 3-month-follow-up

  9. Screening for Depression

    A culturally grounded assessment measure developed in close collaboration with a team of Afghan experts explored current depressive symptoms

    Time frame: Assessment at 12-month-follow-up

07

Study locations

1 site
  • Counseling Center Mazar-e-Sharif
    Mazari Sharif, Balkh, Afghanistan
08

References and documents

Publications

  • Ayoughi S, Missmahl I, Weierstall R, Elbert T. Provision of mental health services in resource-poor settings: a randomised trial comparing counselling with routine medical treatment in North Afghanistan (Mazar-e-Sharif). BMC Psychiatry. 2012 Feb 29;12:14. doi: 10.1186/1471-244X-12-14. PubMed 22375947 ↗
09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Aug 9, 2011, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT01155687
Lead sponsor
University of Konstanz
Collaborators
European Union
First posted
Jul 2, 2010
Start date
Sep 2009
Primary completion
Jul 2010
Completion
Jul 2010
Last update
Aug 9, 2011

Study contacts

Thomas Elbert, Dr.
principal investigator · University of Konstanz
Sarah Ayoughi
principal investigator · University of Konstanz

Oversight

Data monitoring committee
Yes
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Jun 2010. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion